Paragon 28

Paragon 28, Inc. engages in operation of an orthopedic foot and ankle company. Its products include bone graft harvest system, bone marrow aspirate kits, and soft tissue fixation system. The company was founded by Albert DaCosta, Frank Bono, Jim Riegler and Lee Rosenthal in 2010 and is headquartered in Englewood, CO.

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Paragon 28 reports strong revenue growth and strategic initiatives outlook

Paragon 28 delivered robust financial results in Q4 2022 and full-year 2022, driven by strong revenue growth in the U.S. and international markets.
While facing challenges in achieving profitability and commercializing new technologies, the company's focus on innovation and market expansion presents opportunities for future growth.
With a solid liquidity position and strategic initiatives in place, Paragon 28 is well-positioned to capitalize on market opportunities and drive continued performance.
Investors can look forward to the company's projected revenue growth in 2023 and advancements in technology adoption for improved patient outcomes.

Paragon 28 reports record Q1 revenue, eyes global growth opportunities

Paragon 28 delivered robust financial performance in Q1 2023, driven by strong revenue growth in the U.S. and internationally. While challenges in achieving profitability persist, the company's strategic focus on product development and global market expansion positions it for continued success. Opportunities for growth include optimizing sales force efficiency, launching new products, and capitalizing on international market strength.

Paragon 28 reports strong Q2 performance, eyes international expansion

Paragon 28's Q2 2023 earnings call reflects robust financial performance, driven by international growth and successful product launches.
While facing supply chain challenges and anticipating a growth slowdown, the company remains focused on expanding its market reach and product offerings.
Investments in key markets and a strategic focus on emerging growth drivers underscore Paragon 28's commitment to sustained revenue growth.
Prudence in guidance and operational planning amidst uncertainties highlights the company's proactive approach to managing challenges and seizing opportunities.

Paragon 28 reports steady Q3 growth amidst supply chain challenges

Paragon 28's Q3 2023 earnings call highlighted steady revenue growth, product innovation, and strategic investments driving performance.
While facing supply chain challenges and billing day impacts, the company's focus on market-specific strategies and surgeon training remains a strength.
Securing a new credit facility and reaffirming revenue guidance underscore Paragon 28's commitment to future growth and market leadership.

Paragon 28 reports robust Q4 performance, eyes growth in 2024

Paragon 28's strong performance in Q4 2023, coupled with expectations for growth in 2024, positions the company well for the future. Despite challenges like supply chain issues, the company's focus on innovation and market expansion presents significant opportunities. By maintaining accountability and leveraging market opportunities, Paragon 28 aims to drive continued success.

Paragon 28 reports record Q1 revenue, eyes growth opportunities

Paragon 28's Q1 2024 performance reflects strong revenue growth and strategic product launches.
While facing challenges like negative cash flow and increased SG&A expenses, the company remains optimistic.
Opportunities lie in upcoming product launches, market expansion, and engagement with investors.
Overall, Paragon 28's resilience and growth trajectory position it well for future success in the medical devices sector.

Paragon 28 reports record revenue and positive EBITDA in Q3

Paragon 28's Q3 2024 performance reflects strong revenue growth, product innovation, and a milestone in positive adjusted EBITDA post-IPO.
The company's emphasis on operational efficiency and cost optimization positions it well for sustained profitability and growth.
While facing challenges in cash flow and margin stabilization, Paragon 28 has opportunities to capitalize on its strengths and drive further expansion.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

NEW YORK, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Paragon 28, Inc. ("Paragon 28, Inc." or the "Company") (NYSE: FNA) of a class action securities lawsuit.

Paragon 28, Inc. Class Action: Levi & Korsinsky Reminds Paragon 28, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 29, 2024 – FNA

NEW YORK, NY / ACCESSWIRE / November 18, 2024 / If you suffered a loss on your Paragon 28, Inc. (NYSE:FNA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/paragon-28-inc-lawsuit-submission-form?prid=112442&wire=1 or contact Joseph E. Levi, Esq.

Levi & Korsinsky Notifies Paragon 28, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - FNA

NEW YORK, Nov. 18, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Paragon 28, Inc. (NYSE: FNA) between May 5, 2023 and September 20, 2024, both dates inclusive (the “Class Period”), and those who purchased Paragon 28 call options or sold put options during the Class Period, of the November 29, 2024 lead plaintiff deadline in the securities class action first filed by the Firm.

FNA DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Paragon 28, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – FNA

NEW YORK, NY / ACCESSWIRE / November 18, 2024 / If you suffered a loss on your Paragon 28, Inc. (NYSE:FNA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/paragon-28-inc-lawsuit-submission-form?prid=112402&wire=1 or contact Joseph E. Levi, Esq.

Shareholders That Lost Money on Paragon 28, Inc. (FNA) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More

ENGLEWOOD, Colo.--(BUSINESS WIRE)--Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced that Albert DaCosta, Chairman and CEO, and Chadi Chahine, CFO, will participate in a fireside chat at the 36th Annual Piper Sandler Healthcare Conference on Tuesday, December 3, 2024, at 8:30 a.m. Eastern Time / 6:30 a.m. Mountain Time. A live webcast, as well as the archived recording, will be available on the investor re.

Paragon 28 to Present at the 36th Annual Piper Sandler Healthcare Conference

NEW YORK CITY, NY / ACCESSWIRE / November 18, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Paragon 28, Inc. ("Paragon 28" or "the Company") (NYSE:FNA) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Paragon 28 securities between May 5, 2023 through September 20, 2024, inclusive (the "Class Period").

FNA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Paragon 28, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

NEW YORK , Nov. 18, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Paragon 28, Inc. (NYSE: FNA). Shareholders who purchased shares of FNA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

Paragon 28, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - FNA

LOS ANGELES, CA / ACCESSWIRE / November 17, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Paragon 28, Inc. ("Paragon 28" or "the Company") (NYSE:FNA) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between May 5, 2023 and August 8, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before November 29, 2024.

Paragon 28, Inc. Is Being Sued For Violating Securities Laws And The Schall Law Firm Urges Affected Investors To Reach Out

NEW YORK CITY, NY / ACCESSWIRE / November 17, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Paragon 28, Inc. ("Paragon 28" or "the Company") (NYSE:FNA) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Paragon 28 securities between May 5, 2023 through September 20, 2024, inclusive (the "Class Period").

FNA Stockholders Have Opportunity to Lead Paragon 28, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!

LOS ANGELES, CA / ACCESSWIRE / November 16, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Paragon 28, Inc. ("Paragon 28" or "the Company") (NYSE:FNA) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between May 5, 2023 and August 8, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before November 29, 2024.

Stockholders With Losses Are Invited To Join The Schall Law Firm In A Securities Fraud Case Against Paragon 28 Inc

NEW YORK, Nov. 16, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Paragon 28, Inc. (NYSE: FNA) between May 5, 2023 and September 20, 2024, both dates inclusive (the “Class Period”), and those who purchased Paragon 28 call options or sold put options during the Class Period, of the November 29, 2024 lead plaintiff deadline in the securities class action first filed by the Firm.

FNA DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Paragon 28, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – FNA

NEW YORK, NY / ACCESSWIRE / November 15, 2024 / If you suffered a loss on your Paragon 28, Inc. (NYSE:FNA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/paragon-28-inc-lawsuit-submission-form?prid=112175&wire=1 or contact Joseph E. Levi, Esq.

Lost Money on Paragon 28, Inc.(FNA)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky

WASHINGTON, DC / ACCESSWIRE / November 15, 2024 / Cohen Milstein alerts investors that a complaint was filed on October 18, 2024 in the U.S. District Court for the District of Colorado against medical device company Paragon 28, Inc. ("Paragon 28" or the "Company). The complaint alleges that certain current and former officers made false and misleading statements to investors about financial statements and internal controls in violation of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934.

Paragon 28, Inc. Securities Fraud Lawsuit Pending

The consensus price target hints at a 52.6% upside potential for Paragon 28, Inc. (FNA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

How Much Upside is Left in Paragon 28, Inc. (FNA)? Wall Street Analysts Think 52.58%

NEW YORK, NY / ACCESSWIRE / November 15, 2024 / If you suffered a loss on your Paragon 28, Inc. (NYSE:FNA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/paragon-28-inc-lawsuit-submission-form?prid=112126&wire=1 or contact Joseph E. Levi, Esq.

Investors who lost Money on Paragon 28, Inc. (FNA) should contact Levi & Korsinsky about Pending Class Action - FNA

NEW YORK, NY / ACCESSWIRE / November 15, 2024 / If you suffered a loss on your Paragon 28, Inc. (NYSE:FNA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/paragon-28-inc-lawsuit-submission-form?prid=112069&wire=1 or contact Joseph E. Levi, Esq.

Investors who lost money on Paragon 28, Inc. (FNA) should contact Levi & Korsinsky about pending Class Action - FNA

NEW YORK, NY / ACCESSWIRE / November 14, 2024 / If you suffered a loss on your Paragon 28, Inc. (NYSE:FNA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/paragon-28-inc-lawsuit-submission-form?prid=112015&wire=1 or contact Joseph E. Levi, Esq.

Paragon 28, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky Before November 29, 2024 to Discuss Your Rights – FNA

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Paragon 28 To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in Paragon 28 between May 5, 2023 and September 20, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330  (Ext. 1310). [You may also click here for additional information] NEW YORK , Nov. 14, 2024 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Paragon 28, Inc. ("Paragon 28" or the "Company") (NYSE: FNA) and reminds investors of the November 29, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Paragon 28

LOS ANGELES, CA / ACCESSWIRE / November 14, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Paragon 28, Inc. ("Paragon 28" or "the Company") (NYSE:FNA) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between May 5, 2023 and August 8, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before November 29, 2024.

Shareholders Are Invited To Join The Schall Law Firm In A Fraud Case Against Paragon 28 Inc

NEW YORK, NY / ACCESSWIRE / November 14, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Paragon 28, Inc. ("Paragon 28" or the "Company") (NYSE:FNA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Paragon 28, Inc. – FNA

NEW YORK CITY, NY / ACCESSWIRE / November 14, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Paragon 28, Inc. ("Paragon 28" or "the Company") (NYSE:FNA) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Paragon 28 securities between May 5, 2023 through September 20, 2024, inclusive (the "Class Period").

FNA Investors Have Opportunity to Lead Paragon 28, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!

NEW YORK , Nov. 14, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Paragon 28, Inc. (NYSE: FNA). Shareholders who purchased shares of FNA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

Paragon 28, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before November 29, 2024 to Discuss Your Rights - FNA

Paragon 28, Inc (NYSE:FNA ) Q3 2024 Results Conference Call November 13, 2024 4:30 PM ET Company Participants Matthew Brinckman - Senior Vice President, Strategy and Investor Relations Albert DaCosta - Chairman and Chief Executive Officer Chadi Chahine - Chief Financial Officer and Executive Vice President, Supply Chain Conference Call Participants Phillip Dantoin - Piper Sandler Caitlin Cronin - Canaccord Genuity Mike Matson - Needham David Turkaly - Citizens JMP Craig Bijou - Bank of America Brandon Vazquez - William Blair Operator Thank you all for joining. I would like to welcome you all to the Paragon 28 Third Quarter 2024 Earnings Conference Call [Operator Instructions].

Paragon 28, Inc (FNA) Q3 2024 Earnings Call Transcript

NEW YORK, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Paragon 28, Inc. ("Paragon 28, Inc." or the "Company") (NYSE: FNA) of a class action securities lawsuit.

Class Action Filed Against Paragon 28, Inc. (FNA) - November 29, 2024 Deadline to Join – Contact Levi & Korsinsky

LOS ANGELES, CA / ACCESSWIRE / November 13, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Paragon 28, Inc. ("Paragon 28" or "the Company") (NYSE:FNA) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between May 5, 2023 and August 8, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before November 29, 2024.

News for Paragon 28 Stock (FNA)